Dr. Macenski has almost 30 years of biomedical research and management experience spanning both academia and the medical device industry. He began his career as a psychiatry faculty member at the University of Texas Medical School examining central nervous system drug effects on behavior. After a successful 10-year academic run, Dr. Macenski refocused on clinical research and medical devices. Over the last 15 years he has held various management positions in the medical device industry including Clinical Hip Operations Manager, Scientific Affairs Manager for biologic research and executive leadership positions as Global Director of Clinical Affairs at Zimmer Spine and Head of Clinical Affairs at Miromatrix. He possesses substantial experience in experimental design and clinical trial management as well as a thorough understanding of regulatory environments including FDA and ISO. He has successfully recruited, managed and developed talent and has managed off-site locations in the US and EU. Dr. Macenski was awarded a Ph.D. in behavioral pharmacology from the University of Minnesota. His scholarship is evidenced by authorship of numerous peer-reviewed scientific articles across multiple diverse fields including CNS drug action, human drug abuse, behavioral economics, spine pathology, autologous proteins, and osteoarthritis. He has over 50 conference presentations and is currently an associate editor for The Spine Journal.